Cargando…
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
BACKGROUND: Little is known about the incidence of virological failure among Human Immunodeficiency virus (HIV) infected adults after Uganda transitioned from Zidovidine/Lamivudine/ Nevirapine (AZT/3TC/NVP) to Tenofovir/Lamivudine/Efavirenze (TDF/3 T/EFV) as a first-line anti-retroviral therapy (ART...
Autores principales: | Izudi, Jonathan, Alioni, Sunday, Kerukadho, Emmanuel, Ndungutse, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084428/ https://www.ncbi.nlm.nih.gov/pubmed/27793124 http://dx.doi.org/10.1186/s12879-016-1952-x |
Ejemplares similares
-
HIV serostatus disclosure among people living with HIV/AIDS in Mwanza, Tanzania
por: Yonah, Gladys, et al.
Publicado: (2014) -
Disclosure of HIV serostatus and condomless sex among men living with HIV/AIDS in Florida
por: Cook, Christa L., et al.
Publicado: (2018) -
HIV serostatus disclosure in the treatment cascade: evidence from Northern Tanzania
por: Ostermann, Jan, et al.
Publicado: (2015) -
Experiences of HIV Positive Serostatus Disclosure to Sexual Partner Among Individuals in Discordant Couples in Mbarara City, Southwestern Uganda
por: Atwijukiire, Humphrey, et al.
Publicado: (2022) -
Predictors of HIV serostatus disclosure to partners among HIV-positive pregnant women in Morogoro, Tanzania
por: Kiula, Elizabeth S, et al.
Publicado: (2013)